Found 16 matching trials
Treatment of Hemophilia A Patients With FVIII Inhibitors
N/AThis is a non-interventional, multicenter, observational, international stu...
Location
Arthur M. Blank Hospital
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
PHASE3The main aim of the study is to evaluate the effectiveness of prophylaxis w...
Location
University of Alabama at Birmingham
A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
PHASE3The EMPOWER trial is a pilot multi-center, placebo-controlled (normal salin...
Location
St. Michael's Hospital
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)
PHASE3The main aim of the study is to check effectiveness of rVWF (vonicog alfa) ...
Location
Arkansas Children's Hospital Research Institute
Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
PHASE4The purpose of this study is to test the safety and effectiveness of Humate...
Location
Multiple Locations
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
PHASE3The main aim of the study is to check effectiveness, side effects, and tole...
Location
University of Colorado Hemophilia & Thrombosis Center
Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia A
PHASE2The aim of this study are to
* assess the efficacy of Biostate® \[Study Pr...
A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.
PHASE2The main objectives of the study were
* to compare the pharmacokinetics (P...
Location
Hematology Dept., Sackler School of Medicine, Tel Aviv University
Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
PHASE2The aim of this study is to assess the pharmacokinetics (PK), efficacy, and...
Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A
PHASE1This Phase 1/2 study will be a dose escalation study in adults in 5 cohorts...
Location
Specialized Hospital for Active Treatment of Hematological Diseases EAD Clinic of Clinical Hematology